Department of Obstetrics, Gynecology and Perinatology, P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.
Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Gynecol Endocrinol. 2021 Feb;37(2):162-165. doi: 10.1080/09513590.2020.1855634. Epub 2020 Dec 4.
Endometriosis is a benign gynecological disease, which significantly impairs fertility. However, the contribution of specific hormonal parameters to the proper diagnosis of endometriosis in infertility states has not been adequately determined. The aim of this study was to compare ant-Mullerian hormone (AMH), prolactin and estradiol concentrations between infertile women with and without endometriosis, as well as to estimate the effect of endometrioid heterotopia on ovarian reserve.
In this cross-sectional study, mean baseline serum AMH, prolactin and estradiol levels were assessed in infertile women with and without endometriosis. Descriptive statistics are presented in the form of arithmetic mean ± standard deviation (SD). The comparison of indicators was performed by using parametric (-test) and non-parametric criteria (Mann-Whitney).
Seventy-two infertile women with endometriosis (group A; mean age: 32 ± 4.3 years) and 77 infertile women without endometriosis (group B; mean age: 32.4 ± 3.7 years) were studied. Mean baseline prolactin concentrations were higher in group A (16.9 ± 5.7 ng/mL) compared with group B (15 ± 4.3 ng/mL; = .023), whereas mean AMH concentrations were lower (2.8 ± 1.9 ng/mL and 3.5 ± 1.8 ng/mL, respectively; = .018). The highest prolactin and the lowest AMH concentrations were found in women with ovarian endometriomas than in those with deep infiltrative endometriosis and adenomyosis. There was no difference in estradiol levels between groups.
Infertile women with endometriosis demonstrated higher prolactin and lower AMH concentrations, compared with infertile women without endometriosis. The highest prolactin and the lowest AMH concentrations were observed in patients with ovarian endometriomas.
子宫内膜异位症是一种良性妇科疾病,它会显著降低生育能力。然而,特定激素参数对不孕患者中子宫内膜异位症的正确诊断的贡献尚未得到充分确定。本研究旨在比较不孕伴或不伴子宫内膜异位症妇女的抗苗勒管激素(AMH)、催乳素和雌二醇浓度,并评估子宫内膜异位灶对卵巢储备的影响。
在这项横断面研究中,评估了不孕伴或不伴子宫内膜异位症妇女的基础血清 AMH、催乳素和雌二醇的平均水平。用算术平均值表示描述性统计数据 ± 标准差(SD)。采用参数(t 检验)和非参数(Mann-Whitney)标准比较指标。
研究了 72 例子宫内膜异位症不孕妇女(A 组;平均年龄:32 ± 4.3 岁)和 77 例无子宫内膜异位症不孕妇女(B 组;平均年龄:32.4 ± 3.7 岁)。A 组的基础催乳素浓度(16.9 ± 5.7 ng/mL)高于 B 组(15 ± 4.3 ng/mL; = .023),而 AMH 浓度较低(分别为 2.8 ± 1.9 ng/mL 和 3.5 ± 1.8 ng/mL; = .018)。卵巢子宫内膜异位瘤患者的催乳素最高,AMH 最低,而深部浸润性子宫内膜异位症和子宫腺肌病患者则较低。两组的雌二醇水平无差异。
与无子宫内膜异位症的不孕妇女相比,子宫内膜异位症不孕妇女的催乳素水平较高,AMH 浓度较低。卵巢子宫内膜异位瘤患者的催乳素最高,AMH 最低。